LEADER 00000nam  2200000 a 4500 
001    28529367 
003    OCoLC 
005    19950417123658.0 
008    940421s1993    xxum         a000 0 eng d 
040    NLM|cNLM|dTOL|dGZM|dCIN|dAS|dEAS 
082  4 616.123 
090    RC685.C6|bS27 1993 
100 1  Sarma, Syam 
245 14 The gemfibrozil cost-benefit model :|banalysis of data 
       from the Helsinki Heart Study, model development, and 
       extension to the California Medicaid population /|cSyam 
       Sarma 
260    Santa Monica, CA (1700 Main St., P.O. Box 2138, Santa 
       Monica  90407-2138) :|bRAND,|c1993 
300    ix, 139 p. :|bill ;|c28 cm 
490 1  Dissertation 
500    "RAND Graduate School." 
500    "RSGD-105." 
504    Includes bibliographical references (p. 127-139) 
650  0 Coronary heart disease|xTreatment 
650  0 Coronary heart disease|xPrevention|zFinland 
650  0 Digoxin 
650  0 Medicaid|zCalifornia 
710 2  Rand Graduate School 
830  0 Rand Graduate School dissertation ;|vRGSD-105